Nomogram for Predicting Prognosis and Adjuvant Chemotherapy Benefits in Early-stage Invasive Mucinous Lung Adenocarcinoma

被引:0
|
作者
He, H. [1 ]
Zhao, M. [2 ]
Yang, D. [2 ]
Sun, S. [1 ]
He, L. [1 ]
Ma, M. [3 ]
She, Y. [2 ]
Chen, C. [2 ]
机构
[1] Lanzhou Univ, Clin Med Coll 1, Lanzhou, Peoples R China
[2] Shanghai Pulm Hosp, Shanghai, Peoples R China
[3] Lanzhou Univ, Hosp 1, Lanzhou, Peoples R China
关键词
invasive mucinous adenocarcinoma; stage IA-IIA; nomogram;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP07.01-01
引用
收藏
页码:S506 / S507
页数:2
相关论文
共 50 条
  • [1] Nomogram for predicting prognosis and identifying chemotherapy beneficiaries for completely resected stage I invasive mucinous lung adenocarcinoma
    He, Hua
    Zeng, Xiaofei
    Zhang, Quan
    Hu, Wenteng
    Huang, Rongfei
    Zhao, Hongxin
    Sun, Shuo
    Lin, Ruijiang
    Yue, Peng
    Han, Biao
    Ma, Minjie
    Chen, Chang
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (01) : 95 - 121
  • [2] A potential biomarker based on clinical-radiomics nomogram for predicting survival and adjuvant chemotherapy benefit in resected node-negative, early-stage lung adenocarcinoma
    Ma, Xiaoling
    Lv, Wenzhi
    Wang, Cong
    Tu, Dehao
    Qiao, Jinhan
    Fan, Chanyuan
    Niu, Jiandong
    Zhou, Wen
    Liu, Qiuyu
    Xia, Liming
    JOURNAL OF THORACIC DISEASE, 2022, 14 (01) : 1 - +
  • [3] Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy
    Takahashi, Yusuke
    Eguchi, Takashi
    Bains, Sarina
    Adusumilli, Prasad S.
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (04)
  • [4] Prognosis of early-stage lung adenocarcinoma in young patients
    Jia, Yaping
    Ji, Qiuliang
    Zhang, Lei
    She, Yunlang
    Su, Minghang
    Shi, Zhe
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2023, 50 (10) : 826 - 832
  • [5] Predicting Response to Chemotherapy With Early-Stage Lung Cancer
    Rosell, Rafael
    Taron, Miquel
    Massuti, Bartomeu
    Mederos, Nuria
    Magri, Ignacio
    Santarpia, Mariacarmela
    Miguel Sanchez, Jose
    CANCER JOURNAL, 2011, 17 (01): : 49 - 56
  • [6] Predictors of benefits from adjuvant chemotherapy in stage IB lung adenocarcinoma
    Jung-Jyh, H.
    Hsu, W. H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S596 - S596
  • [7] NOMOGRAM FOR PREDICTING 5-YEAR RECURRENCE IN EARLY-STAGE ADENOCARCINOMA OF CERVIX
    Park, J.
    Baek, M. H.
    Kim, D. Y.
    Suh, D. S.
    Kim, J. H.
    Kim, Y. M.
    Kim, Y. T.
    Nam, J. H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 200 - 200
  • [8] Development and validation of a nomogram for predicting survival in patients with surgically resected lung invasive mucinous adenocarcinoma
    Zhang, Guochao
    Wang, Xuefei
    Jia, Jia
    Zuo, Zhichao
    Wang, Lide
    Gao, Shugeng
    Xue, Liyan
    Xue, Qi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (12) : 4445 - +
  • [9] Micropapillary Predominant Lung Adenocarcinoma in Stage IA Benefits from Adjuvant Chemotherapy
    Wang, Cong
    Yang, Jinguo
    Lu, Ming
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (06) : 2051 - 2060
  • [10] Micropapillary Predominant Lung Adenocarcinoma in Stage IA Benefits from Adjuvant Chemotherapy
    Cong Wang
    Jinguo Yang
    Ming Lu
    Annals of Surgical Oncology, 2020, 27 : 2051 - 2060